CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE
1B 型假性甲状旁腺功能减退症基因的克隆
基本信息
- 批准号:6312282
- 负责人:
- 金额:$ 7.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pseudohypoparathyroidism (PHP) type 1 is an autosomal dominant disorder characterized by biochemical hypoparathyroidism due to resistance of target tissues to parathyroid hormone (PTH). Two fundamentally different forms of PHP type 1 have been described. In PHP type 1a, mutations in the GNAS1 gene lead to reduced expression or activity of the alpha subunit of the G protein (Gs alpha) that couples heptahelical receptors for PTH and many other hormones to activation of adenylyl cyclase. Accordingly, widespread deficiency of Gs alpha is associated with resistance not only to PTH but also to other hormones that act by stimulating adenylyl cyclase. By contrast, Gs alpha is normal in PHP type 1b, and hormone resistance is limited to PTH target tissues. These observations had suggested that the defect in PHP type 1b was the type 1 PTH receptor, but molecular analysis of this gene has not revealed mutations. The goal of this project is to identify and characterize the gene for PHP type 1b. We have used linkage analysis to assign the locus for PHP type 1b (designated PHP1b) to 10q26. This region contains a candidate gene that encodes the type 5 G protein-coupled receptor kinase (GRK 5), a protein kinase that can phosphorylate and desensitize the type 1 PTH receptor. To determine the PHP1b gene, a positional cloning strategy will be used involving the following approaches: (1) Further refine the PHP1b locus first by haplotype analysis of three additional PHP type 1b families we have ascertained, and subsequently by further analysis of all families using additional polymorphic markers mapped to this region. (2) Screen publicly available YAC clones and assemble a linear contig spanning the locus, and increase the resolution of the physical map. (3) Identify coding sequences in this region by review of publicly available EST maps, screening cDNA libraries by GeneTrapper methodology, and by exon-trapping. (4) Characterize transcripts through evaluation of homology to other known genes, patterns of tissue-specific expression, and cross-species conservation. (5) Perform mutational analysis of genomic DNA samples from familial and sporadic cases. Once the PHP1b gene is identified, the long-range goal will be to characterize the function of the gene product, to examine genotype-phenotype correlations, and to understand its role in regulating expression or action of the PTH receptor in health and disease.
假性甲状旁腺功能减退症(PHP) 1型是一种常染色体显性遗传病,以靶组织对甲状旁腺激素(PTH)的抵抗为特征,表现为生化甲状旁腺功能减退症。已经描述了PHP类型1的两种根本不同的形式。在PHP 1a型中,GNAS1基因的突变导致G蛋白α亚基(Gs α)的表达或活性降低,该亚基偶联PTH七螺旋受体和许多其他激素以激活腺苷酸环化酶。因此,Gs α的普遍缺乏不仅与对甲状旁腺激素的抗性有关,而且与其他通过刺激腺苷酸环化酶起作用的激素的抗性有关。相比之下,Gs α在1b型PHP中是正常的,激素抵抗仅限于PTH靶组织。这些观察结果表明,PHP 1b型的缺陷是1型PTH受体,但该基因的分子分析未显示突变。该项目的目标是鉴定和表征PHP 1b型的基因。我们使用连锁分析将PHP1b型(指定为PHP1b)的位点定位为10q26。该区域包含一个编码5型G蛋白偶联受体激酶(grk5)的候选基因,grk5是一种可以磷酸化和脱敏1型甲状旁腺激素受体的蛋白激酶。为了确定PHP1b基因,将使用定位克隆策略,包括以下方法:(1)首先通过对我们确定的另外三个PHP1b型家族的单倍型分析来进一步完善PHP1b位点,然后使用附加的多态性标记对该区域的所有家族进行进一步分析。(2)筛选公开可用的YAC克隆并组装一个跨越位点的线性配置,并提高物理地图的分辨率。(3)通过查阅公开的EST图谱、GeneTrapper方法筛选cDNA文库和外显子捕获来鉴定该区域的编码序列。(4)通过评估转录本与其他已知基因的同源性、组织特异性表达模式和跨物种保护来表征转录本。(5)对家族性和散发性病例的基因组DNA样本进行突变分析。一旦确定了PHP1b基因,长期目标将是表征该基因产物的功能,检查基因型-表型相关性,并了解其在调节PTH受体在健康和疾病中的表达或作用中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL ALAN LEVINE其他文献
MICHAEL ALAN LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL ALAN LEVINE', 18)}}的其他基金
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
- 批准号:
10581278 - 财政年份:2022
- 资助金额:
$ 7.57万 - 项目类别:
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
- 批准号:
9388011 - 财政年份:2017
- 资助金额:
$ 7.57万 - 项目类别:
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
- 批准号:
9980393 - 财政年份:2017
- 资助金额:
$ 7.57万 - 项目类别:
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
- 批准号:
10170333 - 财政年份:2017
- 资助金额:
$ 7.57万 - 项目类别:
The Role of GCM2 in Parathyroid Gland Homeostasis
GCM2 在甲状旁腺稳态中的作用
- 批准号:
8437490 - 财政年份:2012
- 资助金额:
$ 7.57万 - 项目类别:
The Role of GCM2 in Parathyroid Gland Homeostasis
GCM2 在甲状旁腺稳态中的作用
- 批准号:
8687644 - 财政年份:2012
- 资助金额:
$ 7.57万 - 项目类别:
The Role of GCM2 in Parathyroid Gland Homeostasis
GCM2 在甲状旁腺稳态中的作用
- 批准号:
8871435 - 财政年份:2012
- 资助金额:
$ 7.57万 - 项目类别:
The Role of GCM2 in Parathyroid Gland Homeostasis
GCM2 在甲状旁腺稳态中的作用
- 批准号:
8549201 - 财政年份:2012
- 资助金额:
$ 7.57万 - 项目类别:
GCMB- Master Regulator of Parathyroid Function
GCMB-甲状旁腺功能的主调节器
- 批准号:
7729158 - 财政年份:2009
- 资助金额:
$ 7.57万 - 项目类别:
GCMB- Master Regulator of Parathyroid Function
GCMB-甲状旁腺功能的主调节器
- 批准号:
7895882 - 财政年份:2009
- 资助金额:
$ 7.57万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 7.57万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:














{{item.name}}会员




